
Cardinal Health (CAH) Stock Forecast & Price Target
Cardinal Health (CAH) Analyst Ratings
Bulls say
Cardinal Health is positioned for durable fundamental outperformance because F1Q27 results and raised FY27 guidance reinforce broad-based profit growth across Pharma and Other, with adjusted EPS now expected at $12.80-$13.00 and Pharma profit growth at 10%-12%. Its core distribution scale, strength in specialty and generics, and vertical integration into higher-margin services such as Sonexus and nuclear medicine should expand operating income, while the Other segment’s revenue and profit growth of 12%-14% and 17%-20% adds a meaningful growth engine. Even with slower Pharma growth in F2Q/F3Q from renewal timing, continued customer wins, biosimilar adoption, and specialty-drug momentum support a stronger FY27 and a widening moat versus peers.
Bears say
Cardinal Health is facing a fundamental risk profile that is unfavorable because its core drug distribution business operates in a highly competitive market with razor-thin low-single-digit gross margins, while supply chain disruptions and input cost inflation could further compress profitability. Its growth case is also fragile: the tailwinds from generics are expected to taper off, specialty growth may prove less durable, and execution risk around the GMPD improvement plan, Sonexus expansion, and capital deployment could limit margin expansion. At the same time, the stock trades at 18x NTM+1 PE, over 2-standard deviations above its 5-year average, leaving limited valuation support if nuclear FDA approvals, radioisotope supply, or healthcare policy changes disappoint.
This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.
Cardinal Health (CAH) Analyst Forecast & Price Prediction
Start investing in Cardinal Health (CAH)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Cardinal Health (CAH) Forecast
Cardinal Health (CAH) Analyst Forecast & Price Prediction
Start investing in Cardinal Health (CAH)
Order type
Buy in
Order amount
Est. shares
0 shares